Precision Reprogramming of Lung Cancer Biomarkers via CRISPR/Cas9: A Paradigm Shift in Personalized Immunotherapy. J. Anal. Oncol. [Internet]. 2025 Dec. 30 [cited 2026 May 7];14:96-105. Available from: https://neoplasiaresearch.com/index.php/jao/article/view/917